. Mechanistic insights into isoform-dependent and species-specific regulation of bile salt export pump by farnesoid X receptor.
IR1b (ATG C C C CT TT ACT), and the half ER2 site ( AA CCCT), respectively (mutated nucleotides are underlined). Rat bsep promoter mutants prBSEP(-2kb)-IR1a-Mut, prBSEP(-2kb)-IR1b-Mut, prBSEP(-2kb)-IR1ab-Mut, and prBSEP(-2kb)-ER2-Mut were prepared by mutating the IR1a, IR1b, IR1a and IR1b, and the half ER2 site using prBSEP(-2kb) as templates. Three, four, and three nucleotides were mutated in IR1a ( G GG A CATTGA T CT), IR1b (ATG C C C CT TT ACT), and the half ER2 site ( AAA ACT), respectively. Replacement of human IR1a (hIR1a) with mouse/rat IR1a (m/rIR1a) was achieved through mutagenesis using phBSEP(-2.6kb) as the template, resulting in a chimeric reporter phBSEP(-2.6kb)-m/ rIR1a. Chimeric reporter prBSEP(-2kb)-hIR1a was made through mutagenesis by replacing the mouse/rat IR1a (m/rIR1a) with the human IR1a (hIR1a) using prBSEP(-2kb) as the template. All the mutants were subjected to sequence confi rmation.
Immunohistofl uorescence
Normal human liver tissue sections embedded in paraffi n (ab4348) were obtained from Abcam (Cambridge, MA). Deparaffi nization, antigen retrieval, and immune staining of the sections were carried out basically according to the protocol recommended by the manufactures. Nonspecifi c binding was blocked by using 5% BSA in 1× TBS containing 0.1% TX-100 for 2 h on shaker at room temperature. Three types of primary antibodies (Abs) were applied to individual slides, including rabbit anti-FXR ␣ 1-specifi c Abs (custom-made by the NeoBioLab, Woburn, MA), rabbit anti-FXR Abs (sc-13063), and rabbit IgG (sc-2027, Santa Cruz Biotechnology) as negative controls. AlexaFluor 594 goat anti-rabbit Abs (A11012, Invitrogen) was used as the secondary Abs. The sections were then mounted under a glass cover slip using Vectashield mounting medium containing 1.5 g/ml DAPI (H-1500, Vector Laboratories, Burlingame, CA) as nuclei counterstaining. Images were captured under a confocal microscope at a magnifi cation of 40× (Zeiss AxioImager M2 Imaging System) with fl uorescent and differential interference contrast (DIC) settings.
Reporter luciferase assay
The reporter luciferase activity assays were carried out using the human hepatoma Huh 7 cells and rat hepatocellular carcinoma
We have recently showed that human BSEP expression was severely diminished in patients with hepatocellular carcinoma (HCC) and that such decreased expression of BSEP correlated with altered relative expression of FXR ␣ 1 and FXR ␣ 2 ( 25 ) . Similar to human BSEP, FXR ␣ 2 showed more potent activity than FXR ␣ 1 in transactivating other hepatic FXR targets, including human syndecan-1 and fibrinogens ( 26, 27 ) , whereas mouse bsep and small heterodimeric partner (SHP) were regulated by FXR ␣ 1 and FXR ␣ 2 to similar degrees ( 24 ) . Currently, the underlying mechanisms for such isoform-dependent and species-specifi c regulation of BSEP by FXR are not understood.
In this study, we demonstrate that FXR ␣ 1 and FXR ␣ 2 transactivated human BSEP through two distinct FXR responsive elements (FXRE) that are inverted repeats spaced by one nucleotide (IR1): IR1b and IR1a, respectively. In addition to total FXR expression levels, relative expression of FXR ␣ 1 and FXR ␣ 2 affected human BSEP expression in vitro and in vivo. Further study revealed that sequence variations in IR1a were responsible for the observed species difference in transactivation of BSEP by FXR ␣ 1 and FXR ␣ 2.
EXPERIMENTAL PROCEDURES

Reagents and suppliers
Chemicals and reagents for cloning, site-directed mutagenesis, polymerase-chain reaction (PCR), gel-shift assays, cell cultures, transfection, and luciferase assays were described previously ( 28 ) .
Plasmid constructs
Human, mouse, and rat bsep promoter reporters and mutants, including phBSEP (-2.6kb), pmBSEP(-2.6kb), prBSEP(-2kb), phBSEP(-125b), and phBSEP(-2.6kb)-IR1a-Mut, were prepared previously ( 18, 28, 29 ) . Human pTK-3xhIR1a, mouse/rat pTK3xm/rIR1a, and pTK-3xIR1b reporters were constructed by cloning three copies of the corresponding element into pTK-Luc vector. Element reporters pGL3/p-2xhIR1a and pGL3/p-2xhER2/ IR1a were prepared by cloning two copies of IR1a and ER2/IR1a element in human BSEP promoter into the pGL3/p vector, respectively. Element reporters, including pElement 1-6, were generated by cloning the corresponding element into the pGL3/p vector. Expression plasmids for human nuclear receptors FXR ␣ 2 and FXR ␣ 1 were kindly provided by Dr. Matthew Stoner and Dr. David Mangelsdorf (University of Texas Southwestern Medical Center), respectively.
Liver samples
Snap-frozen healthy human liver samples were obtained through the Mid-Atlantic Division of the Cooperative Human Tissue Network (CHTN) (University of Virginia). The protocol for using human tissues was approved by the Institutional Review Board (IRB) at the University of Rhode Island.
Site-directed mutagenesis
Mutations were introduced into the templates using a QuickChange site-directed mutagenesis kit according to the manufacturer's manual (Stratagene) ( 29 ) . Human BSEP promoter mutants phBSEP(-2.6kb)-IR1b-Mut, phBSEP(-2.6kb)-IR1ab-Mut, and phBSEP(-2.6kb)-ER2-Mut were prepared by mutating the IR1b, IR1a and IR1b, and half ER2 (everted repeat separated by two nucleotides) sites using phBSEP(-2.6kb) as a template. Six, four, and two nucleotides were mutated in IR1a (G ACG C G T GA ATTC), Fig. 1 . Transactivation of BSEP by FXR ␣ 1 and FXR ␣ 2. Human, mouse, and rat bsep promoter reporters phBSEP(-2.6kb), pmBSEP (-2.6kb), and prBSEP(-2kb) were cotransfected into human hepatoma Huh 7 cells with either FXR ␣ 1 or FXR ␣ 2 expression plasmid, followed by treatment of the transfected cells with vehicle DMSO (0.1%) or CDCA (10 M) for 30 h. Reporter transactivation levels as luciferase activities were detected with a dual-luciferase reporter assay system. The fi refl y luminescence was normalized based on the Renilla luminescence signal. The data are presented as mean ± SD of at least three separate experiments. * P < 0.05 between DMSO and CDCA-treated cells (Student t -test).
at Univ of Rhode Island, on January 23, 2019 www.jlr.org Downloaded from (-2.6kb), phBSEP(-2.6kb)-IR1a-Mut, phBSEP(-2.6kb)-IR1b-Mut, or phBSEP(-2.6kb)-IR1ab-Mut. Sixteen hours posttransfection, cells were treated with 10 M CDCA for 24 h. Chromatin preparation and immunoprecipitation (ChIP) assays were performed essentially as described previously ( 28 ) . A test set of primers, BSEP(-260b) and pGL4-R(122), fl anking IR1a and IR1b were used to amplify a 462 bp fragment encompassing sequence from nucleotides Ϫ 260 to +80 in the BSEP promoter and 122 nucleotides in the luciferase gene. A negative control set of primers was included in the assays ( 28 ) .
Living imaging with in vivo imaging system
Sixteen female CD-1 mice between ages 5 and 8 weeks were obtained from Charles River Laboratory (Wilmington, MA) and randomly divided into four groups. Each group of mice was (HCC) L0 cells (kindly provided by Dr. Jonathan Reicher, Brown University) in a 24-well plate as described previously ( 28 ) .
Electrophoretic mobility shift assays
Nuclear extracts of Huh 7 cells transfected with FXR ␣ 1 or FXR ␣ 2 were prepared using the NE-PER Nuclear and Cytoplasmic Extraction kit (Pierce). The electrophoretic mobility shift assays (EMSA) were performed using the LightShift Chemiluminescent EMSA kit (Pierce) as described ( 17 ) . Supershift assays were carried out using polyclonal Abs against human FXR (sc-13063, Santa Cruz Biotechnologies).
Chromatin immunoprecipitation assays
Huh 7 cells seeded in 6-well plates were cotransfected with 400 ng of either FXR ␣ 1 or FXR ␣ 2 and either 400 ng phBSEP associated with dysregulation of BSEP in patients with HCC ( 25 ) . In this study, we extended such fi nding by testing FXR isoform-mediated transactivation of BSEP from three species, including human, mouse, and rat. Consistent with our previous fi ndings, FXR ␣ 2 exhibited much more potent activity in transactivating human BSEP than FXR ␣ 1 in the presence or absence of endogenous FXR agonist chenodeoxycholic acid (CDCA) ( Fig. 1 ). In contrast, both mouse and rat bsep were transactivated by FXR ␣ 1 and FXR ␣ 2 in comparable levels ( Fig. 1 ) . The results demonstrated that human BSEP was differentially regulated by FXR ␣ 1 and FXR ␣ 2 with FXR ␣ 2 being the predominant regulator, whereas mouse and rat bsep were similarly transactivated by the two isoforms.
Relative FXR isoform and total FXR expression affected the expression levels of human BSEP
In our previous studies, it was shown that the relative expression levels of FXR ␣ 1 and FXR ␣ 2 correlated with BSEP expression ( 25 ) . In this study, the comprehensive relationships among FXR isoforms, total FXR expression, and BSEP expression were further investigated. As shown in Fig. 2A , the expression levels of BSEP and total FXR in healthy human liver samples were plotted against FXR ␣ 1/ FXR ␣ 2 ratios using SigmaPlot 3D program. Over 27-and 6-fold differences in BSEP and total FXR expression, respectively, were detected among the liver samples. Consistent with FXR's transactivating role in BSEP regulation, BSEP expression increased along with increase in total FXR. However, the relationship between FXR ␣ 1/FXR ␣ 2 ratios and BSEP expression did not exhibit a single trend ( Fig. 2A ) . At higher levels of total FXR, as expected, BSEP expression decreased as the FXR ␣ 1/FXR ␣ 2 ratios increased. However, at lower levels of total FXR, BSEP expression increased as the FXR ␣ 1/FXR ␣ 2 ratios increased. The data thus indicated that BSEP expression in human hydrodynamically injected with phBSEP(-2.6kb), prBSEP(-2kb), phBSEP(-2.6kb)-m/rIR1a, or prBSEP(-2kb)-hIR1a promoter reporter as described previously ( 25 ) . Luciferase activities were detected by living imaging with in vivo imaging system (IVIS) 48 h postinjection and captured by a CCD camera with an exposure time of 45 s ( 25 ) . The animal protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Rhode Island (URI) and followed the guidelines outlined in the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Quantitative real-time PCR
Total RNA extraction from 14 healthy human and 8 CD-1 mice liver tissues and subsequent cDNA synthesis and TaqMan realtime PCR detection for total FXR and BSEP were carried out as reported ( 17, 25 ) .
Semiquantifi cation of FXR ␣ 1 and FXR ␣ 2
By using human liver cDNA samples as templates, the relative FXR ␣ 1 and FXR ␣ 2 mRNA levels were determined by the semiquantifi cation methods described previously ( 25 ) .
Statistical analysis
Student t -test was applied to pair-wise comparison to determine the statistical signifi cance. Nonparametric Mann-Whitney test was used for pair-wise comparison for nonnormally distributed data. Values of 0.05 or less were considered signifi cant.
RESULTS
Isoform-dependent and species-specifi c regulation of BSEP transactivation by FXR
Four FXR ␣ isoforms (FXR ␣ 1-4) have been identifi ed, with predominant expression of FXR ␣ 1 and FXR ␣ 2 in the liver ( 23, 24 ) . Our previous study showed that human BSEP was regulated by FXR in an isoform-dependent manner and that alteration of isoform expression was determining human BSEP transactivation and that its effects were infl uenced by the total FXR expression levels.
Expression and localization of FXR ␣ 1 and total FXR protein in human liver tissue
Immunohistofl uorescence was carried out to investigate the expression and localization of total FXR and FXR ␣ 1. In our attempt to generate FXR isoform-specifi c Abs, antiserum raised against FXR ␣ 1-specifi c peptide detected FXR ␣ 1 protein specifi cally, whereas antiserum raised against FXR ␣ 2-specifi c peptide recognized both FXR ␣ 2 and FXR ␣ 1 protein (data not shown) because there are only four extract amino acids inserted in FXR ␣ 1 compared with FXR ␣ 2. Therefore, FXR ␣ 1-specifi c Abs and Abs recognizing both FXR ␣ 1 and FXR ␣ 2 were used in the immunohistofluor escent assays. As shown in Fig. 3 , minimal red fl uorescent signals were detected with rabbit IgG as negative controls while FXR ␣ 1 and total FXR proteins were readily detected with FXR ␣ 1-and FXR-specifi c Abs. Both FXR ␣ 1 and total FXR proteins were predominantly present in the cytoplasm. As expected, relatively weaker signals were detected with FXR ␣ 1-specifi c Abs than with FXR-specifi c Abs.
Isoform-dependent transactivation of human BSEP by FXR was not due to a difference in ligand-mediated activation
In the previous experiments, the potent endogenous FXR agonist CDCA was used in evaluating human BSEP transactivation by FXR isoforms. To determine whether FXR ␣ 1-and FXR ␣ 2 -mediated differential transactivation of human BSEP is related to specifi c FXR ligands, a series of FXR endogenous and exogenous ligands were tested for their ability to induce FXR ␣ 1-and FXR ␣ 2-mediated transactivation of human BSEP. The ligands tested include six endogenous bile acids, including cholic acid (CA), CDCA, deoxycholic acid (DCA), lithocholic acid (LCA), ursodeoxycholic acid (UDCA) and glycodeoxycholic acid (GDCA), a natural product guggulsterone, and two synthetic FXR agonists GW4064 and T0901317. As shown in Fig. 4A , all the FXR ligands exhibited similar FXR isoformdependent transactivation of human BSEP regardless their agonistic potency. FXR ␣ 2 consistently transactivated human BSEP at a much higher level than FXR ␣ 1 with each of the ligands.
In contrast to human BSEP, both mouse and rat bsep promoters exhibited comparable transactivation activities by FXR ␣ 1 and FXR ␣ 2, with slightly higher levels with FXR ␣ 2 in the presence of CDCA in Huh 7 cells ( Fig. 1 ) . Considering the possibility that rat or mouse bsep may exhibit a different transactivation pattern by FXR ␣ 1 and FXR ␣ 2 in rat or mouse cells, rat bsep promoter reporter prBSEP(-2kb) was cotransfected with FXR ␣ 1 or FXR ␣ 2 in rat HCC L0 cells, followed by treatment with various FXR ligands. As shown in Fig. 4B , consistent with the data from Huh 7 cells, FXR ␣ 1 and FXR ␣ 2 exhibited similar transactivation levels with most FXR ligands, except for CDCA and LCA. FXR ␣ 2 transactivated rat bsep more potently than did FXR ␣ 1 with CDCA and LCA. However, it should be emphasized that the differences between FXR ␣ 2 and FXR ␣ 1 in transactivating human BSEP in Huh 7 cells were livers was dictated by the FXR ␣ 1/FXR ␣ 2 ratios as well as by total FXR expression levels.
To directly evaluate the effect of FXR ␣ 1/FXR ␣ 2 ratios at various total FXR levels on BSEP transactivation in vitro, a series of mixtures of FXR ␣ 1 and FXR ␣ 2 plasmid DNA in various ratios (from 1:1 to 1.8:1) at various amounts of total FXR (10, 25, or 50 ng) were cotransfected with the human BSEP promoter reporter in Huh 7 cells, followed by treatment with CDCA. As shown in Fig. 2B , a relationship pattern comparable to human liver samples ( Fig. 2A ) was observed in transfected Huh 7 cells. BSEP transactivation gradually decreased as the FXR ␣ 1/FXR ␣ 2 ratios increased at a high level of total FXR plasmid DNA (50 ng) but increased at a low level of total FXR plasmid DNA (10 ng). The minor differences between the two data sets ( Fig. 2 ) may refl ect the fact that the sample size of human liver samples was relatively small. Taken together, the results demonstrated that the ratio of FXR ␣ 1/FXR ␣ 2 played an important role in Previous studies revealed that half nuclear receptor binding site and ER2 (everted repeat separated by two nucleotides) are commonly found adjacent to the IR1 ( 30 ) . A half ER2 motif was identifi ed immediately upstream the IR1a ( Fig. 5C ) . Inclusion of the motif in hER2/ IR1a reporter signifi cantly enhanced FXR ␣ 2-mediated transactivation ( Fig. 5C ), indicating that the half ER2 motif is required for maximal transactivation of human BSEP by FXR ␣ 2. However, FXR ␣ 1 still failed to transactivate the hER2/IR1a reporter, suggesting that FXR ␣ 1 must regulate human BSEP through an additional FXRE.
FXR ␣ 1 transactivated human BSEP through IR1b, a newly identifi ed FXRE
To determine whether the potential additional FXRE is present in the minimal human BSEP promoter, the resultant phBSEP(-125b) reporter was cotransfected with FXR ␣ 1, followed by treatment with DMSO or CDCA. As shown in Fig. 6A , similar to the full-length promoter reporter phBSEP(-2.6kb), FXR ␣ 1 signifi cantly transactivated the minimal promoter reporter, indicating that the potential additional FXRE is located in the minimal promoter region.
Since no FXREs were predicted by bioinformatic analysis in the region, a series of element reporters covering the entire region were constructed and evaluated for their ability to respond to FXR ␣ 1 ( Fig. 6B, C ) . Reporters pElement 1 and 4 exhibited signifi cant induction of activity in response to CDCA in the presence of FXR ␣ 1, whereas no induction was detected with other reporters. The data thus mapped a new functional FXRE (named IR1b) in the overlapped region between pElement 1 and 4 at positions from much more striking than those with rat bsep in rat HCC L0 cells. FXR ␣ 2 was 27.1-or 18.9-fold more potent than FXR ␣ 1 in transacting human BSEP in Huh 7 cells in the presence of CDCA or LCA, whereas only 2.6-or 4.1-fold differences were observed between FXR ␣ 2 and FXR ␣ 1 in transactivating rat bsep in L0 cells with CDCA or LCA.
Taken together, the data indicated that the isoformdependent transactivation of human BSEP by FXR was not due to a difference between FXR ␣ 1 and FXR ␣ 2 in ligand binding or ligand-mediated activation. On the other hand, FXR ␣ 1 and FXR ␣ 2 transactivated rat bsep comparably with most of the FXR ligands.
Isoform-dependent and species-specifi c transactivation of BSEP by FXR was due to a difference in FXRE in BSEP promoters
Early studies identifi ed an FXRE (named IR1a) in the BSEP promoter ( 15, 16 ) . To determine whether the isoformdependent and species-specifi c transactivation of BSEP is due to a differential activation of the IR1a by FXR ␣ 1 and FXR ␣ 2, human and mouse/rat IR1a (hIR1a and m/rIR1a) reporters were constructed and tested for their ability to support FXR ␣ 1 or FXR ␣ 2 transactivation. It should be mentioned that the IR1a sequences are completely conserved in mouse and rat bsep promoters. As shown in Fig. 5A , FXR ␣ 2 signifi cantly transactivated hIR1a reporter, whereas no transactivation was detected in cells transfected with FXR ␣ 1. Conversely, both FXR ␣ 1 and FXR ␣ 2 strongly transactivated m/rIR1a reporter ( Fig. 5B ) . The results thus demonstrated that hIR1a only supported FXR ␣ 2 transactivation, while m/rIR1a was capable of mediating both FXR ␣ 1 and FXR ␣ 2 transactivation. Ϫ 97b to Ϫ 85b ( Fig. 6D ) To determine the relative contribution of IR1a, IR1b, and the half ER2 sites to the transactivation of human and rat bsep by FXR ␣ 1 and FXR ␣ 2, mutational analyses were performed in those elements. Double mutation in IR1a and IR1b was also introduced.
For human BSEP, similar to the IR1a and IR1b double mutant, IR1b mutant completely lost its ability to respond to FXR ␣ 1 ( Fig. 7A ) , suggesting that FXR ␣ 1 regulates human BSEP through IR1b. Although mutation in IR1a decreased FXR ␣ 1-mediated transactivation, signifi cant induction remained ( Fig. 7A ) . More signifi cantly, the fold induction by CDCA over DMSO was comparable between IR1a mutant and wild-type (wt) (13.1 versus 11.3), indicating that IR1a is required for basal activity but not FXR ␣ 1-mediated transactivation. Conversely, mutation in IR1a almost entirely abolished FXR ␣ 2-mediated transactivation as did the double mutant ( Fig. 7B ) , consistent with regulation of human BSEP by FXR ␣ 2 through IR1a. Similarly, the IR1b mutant retained the ability to respond to CDCA in the presence of FXR ␣ 2 with almost identical fold inductions as the wt (7.9 versus 7.4) ( Fig. 7B ) . Mutation in the half ER2 motif markedly reduced FXR ␣ 2-but not FXR ␣ 1-mediated transactivation ( Fig. 7A, B ) . Taken together, the data demonstrated that FXR ␣ 1 and FXR ␣ 2 transactivated human BSEP through IR1b and IR1a, respectively, and that the ER2 motif is required for maximal FXR ␣ 2 transactivation.
Similar mutational analyses were performed with rat bsep promoter to evaluate species differences. As shown in Fig. 7C , mutation in IR1a or IR1b resulted in a decrease in FXR ␣ 1-mediated transactivation. However, signifi cant activation by CDCA remained for both mutants. As expected, the double mutant almost completely lost its ability to respond to CDCA. The results indicated that different from human BSEP, FXR ␣ 1 regulated rat bsep through both IR1a and IR1b. Conversely, mutation in IR1a almost totally abolished FXR ␣ 2-mediated transactivation as did the double mutant, indicating that FXR ␣ 2 regulates rat bsep through IR1a. Although mutation in IR1b decreased FXR ␣ 2-mediated transactivation, signifi cant induction by CDCA was detected with a comparable fold induction to the wt (7.7 versus 6.5) ( Fig. 7D ) , indicating that similar to human BSEP, IR1b is required for basal activity but not for FXR ␣ 2-mediated transactivation. Mutation in the half ER2 site had no detectable effect on FXR ␣ 1-and FXR ␣ 2-mediated transactivation ( Fig. 7C, D ) , suggesting that different from human BSEP, the half ER2 in rat bsep does not play any roles in mediating FXR ␣ 2 transactivation. 
Binding of FXR ␣ 1 and FXR ␣ 2 to IR1a and IR1b in vitro
To determine whether FXR isoforms differentially bind to IR1a and IR1b in vitro, a series of EMSA assays were performed. With hIR1a and m/rIR1a probes, two distinct bands were shifted for both FXR ␣ 1 and FXR ␣ 2, indicating that two DNA/protein complexes were formed ( Fig. 8A , B ) . To determine which band represents the specifi c binding of FXR ␣ 1 or FXR ␣ 2 to the probe, competition assays were carried out. The dominant bottom band was completely competed out by 10× unlabeled wt but not by mutated hIR1a or m/rIR1a oligonucleotide, indicating that the bottom band represented the probe-specifi c complex. To confi rm that FXR ␣ 1 or FXR ␣ 2 is part of the complex, supershift assays with Abs against FXR were performed. Preincubation of FXR Abs with nuclear extracts markedly decreased the shifted band, suggesting that the binding of FXR Abs to FXR interferes with its binding to the hIR1a or m/rIR1a probe, decreasing the formation of the DNA/FXR complexes. The data thus demonstrated that both FXR ␣ 1 and FXR ␣ 2 bound to hIR1a or m/rIR1a abundantly in vitro. The abundant binding of FXR ␣ 1 to hIR1a was not expected since FXR ␣ 1 failed to transactivate hIR1a reporter.
With IR1b as a probe, two similar bands were shifted with FXR ␣ 1 and FXR ␣ 2. Competition EMSA assays concluded that the bottom band was the specifi c one. Incubation of FXR Abs with the complex resulted in a supershifted band ( Fig. 8C ) , indicating that FXR is part of the complex. It should be emphasized that although similarly shifted patterns were observed for both FXR ␣ 1 and FXR ␣ 2, the bands shifted or supershifted with FXR ␣ 1 were much more abundant than those with FXR ␣ 2, suggesting that FXR ␣ 1 has a higher binding affi nity to IR1b than does FXR ␣ 2.
FXR ␣ 1 and FXR ␣ 2 were specifi cally recruited to IR1b and IR1a, respectively, in human BSEP promoter in intact cells Since IR1a and IR1b are located so close to each other, it was challenging to distinguish FXR recruitment to each individual site on the endogenous BSEP promoter. We used human BSEP promoter reporter wt and mutants to perform ChIP assays. Chromatins were prepared from Huh 7 cells cotransfected with FXR ␣ 1 or FXR ␣ 2 with human BSEP promoter wt, IR1a, IR1b, or IR1ab mutant. With FXR ␣ 1, a PCR band was readily detected in cells transfected indicated that FXR ␣ 1 competitively bound to IR1a with FXR ␣ 2 in the IR1a element reporter, which is consistent with the data from EMSA ( Fig. 8A ) . The results also indicated that no competitive binding of FXR ␣ 1 to IR1a occurred in the full-length promoter, which is consistent with the data from the ChIP assays ( Fig. 9A ) . Such discrepancy in FXR ␣ 1's effects on FXR ␣ 2-mediated transactivation of IR1a element and full-length promoter indicated that the context of IR1a played a determinant role in responding to FXR ␣ 1. It was thus concluded that in the content of fulllength promoter , FXR ␣ 1 and FXR ␣ 2 transactivated human BSEP independently through IR1b and IR1a, respectively and that BSEP expression levels were predominately determined by FXR ␣ 2.
Combining the data from transactivation, mutational analysis, EMSA and ChIP assays, it was concluded that FXR ␣ 1 and FXR ␣ 2 regulated human BSEP independently through IR1b and IR1a. On the other hand, mouse and rat bsep are regulated by FXR ␣ 1 through both IR1a and IR1b and by FXR ␣ 2 through IR1a ( Fig. 10C ).
Sequence differences between hIR1a and m/rIR1a were primarily responsible for the species-specifi c transactivation of BSEP by FXR ␣ 1 and FXR ␣ 2
Sequence alignment of IR1a and IR1b in BSEP promoters from seven species including human, pongo pygmaeus, pan troglodytes, horse, dog, rat, and mouse revealed that IR1b was completely conserved ( Fig. 11A ), indicating the with wt promoter when the chromatins were immunoprecipitated with anti-FXR Abs but not with IgG ( Fig. 9A ) . More importantly, a PCR band with a relatively weaker signal was also detected in cells transfected with IR1a mutant. In contrast, no obvious bands were detected in cells transfected with either IR1b mutant or IR1ab double mutant ( Fig. 9A ) . The data thus established that FXR ␣ 1 was specifi cally recruited to IR1b but not IR1a in intact Huh 7 cells. On the other hand, with FXR ␣ 2, a PCR band was readily detected in cells transfected with wt and IR1b mutant, whereas no signals were detected in cells transfected with IR1a and IR1ab double mutant ( Fig. 9B ) . The data thus demonstrated that FXR ␣ 2 was specifi cally recruited to IR1a but not IR1b.
FXR ␣ 1 and FXR ␣ 2 acted independently in transactivating human BSEP
To investigate whether FXR ␣ 1 and FXR ␣ 2 have additive or competitive effects on the transactivation of human BSEP IR1a element reporter and full-length promoter, increasing amounts of FXR ␣ 1 were cotransfected with a constant amount of FXR ␣ 2, followed by detection of the transactivation levels. As shown in Fig. 10A , FXR ␣ 1 competitively decreased FXR ␣ 2-mediated transactivation in cells transfected with IR1a element reporter pGL3/p-2xhIR1a. In contrast, FXR ␣ 1 had minimal effects on FXR ␣ 2-mediated transactivation of the full-length promoter reporter phBSEP (-2.6kb), even at the highest dose ( Fig. 10B ) . The results Fig. 11B , replacement of the hIR1a in the human BSEP promoter reporter phBSEP(-2.6kb) with m/rIR1a resulted in a strong transactivation of the chimeric promoter reporter phBSEP(2.6kb)-m/rIR1a by both FXR ␣ 1 and FXR ␣ 2, a pattern comparable to mouse or rat promoter wt ( Fig. 1 ) . On the other hand, the reciprocal chimera prBSEP(-2kb)-hIR1a in which the m/rIR1a of rat bsep promoter reporter prBSEP(-2kb) was replaced with human hIR1a exhibited an isoform-dependent transactivation by FXR ␣ 1 and FXR ␣ 2 as human BSEP promoter wt ( Fig. 11C ) .
To further confi rm the results, the wt and chimeric promoter reporters were injected into mice, and their transactivation activities in vivo were evaluated by IVIS living imaging. As shown in Fig. 11D , strong luciferase signals were detected in mice injected with wt rat bsep promoter reporter prBSEP(-2.0kb), while no detectable signals were observed in mice received wt human BSEP promoter reporter phBSEP(-2.6kb), indicating that rat bsep promoter has much stronger activity than human BSEP promoter. Replacement of mouse/rat IR1a with human hIR1a in prBSEP(-2.0kb)-hIR1a markedly reduced the signal compared with wt rat bsep promoter reporter. On the other hand, substitution of the human IR1a with mouse/rat m/rIR1a in phBSEP(-2.6kb)-m/rIR1a resulted in noticeable elevation of luciferase signals compared with wt human BSEP promoter reporter. Taken together, the data fi rmly established that the sequence differences in IR1a were primarily responsible for the species-specifi c regulation of BSEP by FXR ␣ 1 and FXR ␣ 2.
To determine whether the observed differences in BSEP promoter activities between mouse and human is refl ected by the endogenous BSEP transcription levels, the BSEP mRNA levels in human and mouse liver tissues were quantifi ed by real-time PCR with GAPDH levels as internal controls. As shown in Fig. 11E , the mRNA level of mouse bsep was signifi cantly higher than that of human BSEP. The data thus demonstrated that mouse bsep was transcribed at a much higher level than human BSEP in vivo.
DISCUSSION
As the limiting step in bile acid enterohepatic circulation, canalicular effl ux of bile acids by BSEP is tightly regulated by the bile acids/FXR signaling pathway. In our previous study, it was found that human BSEP was isoformdependently regulated by FXR, with FXR ␣ 2 being the predominant regulator. The relative expression of FXR ␣ 1 and FXR ␣ 2 was altered in HCC patients and associated with dysregulation of BSEP ( 25 ) . Similar FXR isoformdependent transactivation has been reported for other FXR targets, including ileal bile acid-binding protein ( 24 ) , fi brinogens ( 26 ), syndecan-1 ( 27 ) , and ␣ -crystallin ( 31 ) . However, it is currently not understood how FXR ␣ 1 and FXR ␣ 2 exhibit different activity on those FXR targets. Based on EMSA data, it was postulated that FXR ␣ 2 had a higher binding affi nity than FXR ␣ 1 to the FXRE of the targets ( 24 ) . Such notion is consistent with the fact that importance of the element in regulating BSEP expression. On the other hand, IR1a was less conserved with 62% sequence identity among those species.
To determine whether the species-specifi c regulation of BSEP by FXR ␣ 1 and FXR ␣ 2 is due to the differences in IR1a, two chimeric promoter reporters in which the authentic IR1a the four amino acid residues inserted in FXR ␣ 1 are located immediately after the DNA binding domain (DBD). The insertion may alter the conformational structure in DBD, thus compromising its ability to bind to FXRE. However, in this study, we showed that FXR ␣ 1 and FXR ␣ 2 transactivated human BSEP through two FXREs, IR1b and IR1a, respectively. The question remains how FXR ␣ 1-mediated transactivation through IR1b is much weaker than FXR ␣ 2-mediated activation through IR1a in human BSEP. One possible explanation is that FXR ␣ 1 might have a weaker intrinsic activity than FXR ␣ 2. However, such notion is inconsistent with the results that FXR ␣ 1 transactivated mouse and rat bsep as potently as did FXR ␣ 2 ( Fig. 1 ) . Another more likely explanation is that the sequence and/ or the content of the IR1b are not optimal for maximal activation by FXR ␣ 1.
Considering that FXR ␣ 2-mediated transactivation through IR1a is the predominant pathway regulating human BSEP expression, the question remains regarding the physiological signifi cance of FXR ␣ 1-mediated transactivation through IR1b in regulating human BSEP. One possible physiological function of FXR ␣ 1/IR1b pathway is to support the maximal transactivation of BSEP by the FXR ␣ 2/IR1a pathway. Consistent with such speculation are results from the mutational studies that mutation in IR1b markedly reduced FXR ␣ 2-mediated basal as well as CDCA-induced transactivation of human BSEP ( Fig. 7B ) . Searching the IR1b sequence in the database revealed that IR1b element is present in many promoter regions (data not shown). However, it remains to be determined whether IR1b element is involved in regulating any of those genes.
Our results showed that in addition to total FXR levels, relative FXR isoform expression levels (FXR ␣ 1/FXR ␣ 2 ratios) signifi cantly affected human BSEP expression. In healthy human liver tissues, FXR ␣ 1/FXR ␣ 2 ratios ranged from 1.09 to 1.63, with an average of 1.37, while BSEP expression exhibited 24-fold differences. It was our expectation that as the FXR ␣ 1/FXR ␣ 2 ratios increased, BSEP expression would decrease. However, the actual data revealed that the relationship between FXR ␣ 1/FXR ␣ 2 ratio and BSEP expression was dependent on the total FXR expression levels ( Fig. 2A, B ) . As expected, human BSEP expression decreased as the ratios increased at the higher levels of total FXR. However, in contrast to our expectation, BSEP expression increased as the FXR ␣ 1/FXR ␣ 2 ratio increased at the lower levels of total FXR. We were not able to provide a satisfactory explanation for the relationship exhibited at the lower levels of total FXR. Such phenomenon may be related to FXR ␣ 1's specifi c activation through IR1b. Since IR1b is completely conserved among species, it is reasonable to speculate that FXR ␣ 1-mediated transactivation of human BSEP through IR1b is critical for maintaining BSEP expression in the events of low total FXR levels.
Although FXR ␣ 1 abundantly bound to hIR1a and FXR ␣ 2 weakly associated with IR1b in vitro in EMSAs ( Fig.  8A, C ) , and FXR ␣ 1 competitively decreased FXR ␣ 2-mediated transactivation of IR1a reporter ( Fig. 10A ) , it was concluded that FXR ␣ 1 and FXR ␣ 2 did not bind to hIR1a and IR1b in the full-length promoter content in intact cells, respectively, based on the following considerations: fi rst, recruitments of FXR ␣ 1 to hIR1a and FXR ␣ 2 to IR1b were not detected in intact cells with the ChIP assays ( Fig. 9A, B ) ; second, FXR ␣ 1 failed to transactivate hIR1a reporter ( Fig. 5A ) ; and third, overexpression of FXR ␣ 1 had a negligible effect on FXR ␣ 2-mediated transactivation of the full-length promoter ( Fig. 10B ) , indicating no competition between the two for binding to IR1a. Taken together, the data strongly supported the conclusion that FXR ␣ 1 and FXR ␣ 2 exclusively bind to IR1b and IR1a, respectively, in intact cells. Such discrepancy of FXR binding to FXRE between in vitro and in intact cells indicates that FXR binding to FXRE within cells is governed not only by the sequence but also by the content. Such notion is supported by the fi nding that among the 1.7 million FXREs predicted in the mouse genome, only 1,656 ( 32 ) or 7,794 ( 30 ) FXREs were detected for FXR binding in vivo in the liver.
In the ChIP assays, it was noticed that compared with wt promoter, the recruitment of FXR ␣ 1 to IR1b in the IR1a mutant or FXR ␣ 2 to IR1a in the IR1b mutant was decreased ( Fig. 9A, B ) . One possible explanation for such phenomenon is that mutation in one site has a negative impact on the binding of FXR ␣ 1 or FXR ␣ 2 to the other site due to the proximity of the two sites (18 bases apart). It should be noted that the ChIP assays were carried out on the transfected wt and mutant promoters. Defi nitive evidence for FXR ␣ 1 binding to IR1b or FXR ␣ 2 binding to IR1a in the endogenous BSEP promoter remains to be provided.
In contrast to human BSEP, mouse and rat bsep were comparably transactivated by FXR ␣ 1 and FXR ␣ 2 ( Fig. 1 ) . Mouse and rat m/rIR1a is able to support both FXR ␣ 1-and FXR ␣ 2-mediated transactivation as the FXRE consensus (FXREc: AGGTCA N TGACCT) does (data not shown). Comparing the sequences of hIR1a, IR1b, and m/rIR1a with FXREc, m/rIR1a is the closest to FXREc, followed by IR1b and hIR1a. Detailed analysis of the sequences revealed that a nucleotide G at position 2 is conserved among FXREc, m/rIR1a, and hIR1a but altered to T in IR1b. Therefore, the G at position 2 may play a determinant role in mediating FXR ␣ 2 transactivation. On the other hand, nucleotides A and T in positions 1 and 13 are conserved among FXREc, m/rIR1a, and IR1b, but they are substituted with G and C in hIR1a, suggesting that the A and T in positions 1 and 13 are important for mediating FXR ␣ 1 transactivation. In this study, we also identifi ed a half ER2 site immediately upstream of IR1a ( Fig. 5C ). Characterization of the ER2 half site revealed that it played an important role in achieving maximal transactivation of human BSEP by FXR ␣ 2, but the site had no effects on FXR ␣ 2-mediated transactivation of rat bsep. Such difference in requirement of ER2 for FXR ␣ 2 to achieve maximal BSEP transactivation may relate to the fact that human hIR1a is more remote than mouse/rat m/rIR1a to the FXRE consensus. The imperfect hIR1a needs the half ER2 site to support maximal FXR ␣ 2 transactivation, whereas the optimal m/rIR1a alone has the capability of fully supporting FXR ␣ 2 transactivation.
In addition to the important role played by FXR in regulating bile acid homeostasis ( 33, 34 ) , FXR regulates a myriad of other target genes critical for cholesterol, lipid, and glucose homeostasis (34) (35) (36) (37) , liver regeneration ( 38 ) , and tumorigenesis ( 39, 40 ) . Based on our new fi nding that FXR ␣ 1 and FXR ␣ 2 transactivated human BSEP through two distinct FXREs, it is reasonable to speculate that FXR ␣ 1 and FXR ␣ 2 may preferably regulate different sets of FXR target genes involved in various functional pathways. We are currently searching for those FXR isoformspecifi c target genes.
